Literature DB >> 16509254

Study on susceptibility status in aquatic and adult stages of Aedes aegypti and Ae. albopictus against insecticides at international airports of south India.

S N Sharma1, V K Saxena, Shiv Lal.   

Abstract

A study on susceptibility status in aquatic and adult stages of Aedes aegypti and Ae. albopictus was undertaken at International Airports of Thiruvananthapuram and Cochin located in southern India. WHO standard test kits were used to conduct insecticide susceptibility tests against various organophosphates, organochlorines, carbamates and synthetic pyrethroids. The results indicate that adult Aedes aegypti and Ae. albopictus were resistant to DDT and dieldrin, but susceptible to propoxur, fenitrothion, malathion, deltamethrin, permethrin and lambdacyhalothrin. The susceptibility test conducted on immature stages of Ae. aegypti and Ae. albopictus revealed that they are susceptible to the larvicides commonly used under the National Vector Borne Diseases Control Programme viz. Temephos (0.02 ppm), Fenthion (0.05 ppm) Malathion (1.0 ppm) and Fenitrothion (0.06 ppm).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16509254

Source DB:  PubMed          Journal:  J Commun Dis        ISSN: 0019-5138


  3 in total

1.  Temephos-induced resistance in Aedes aegypti and its cross-resistance studies to certain insecticides from India.

Authors:  S N Tikar; Arkaja Kumar; G B K S Prasad; Shri Prakash
Journal:  Parasitol Res       Date:  2009-02-20       Impact factor: 2.289

2.  Susceptibility of immature stages of Aedes (Stegomyia) aegypti; vector of dengue and chikungunya to insecticides from India.

Authors:  S N Tikar; M J Mendki; K Chandel; B D Parashar; Shri Prakash
Journal:  Parasitol Res       Date:  2008-01-04       Impact factor: 2.289

3.  Multiple insecticide resistance mechanisms in primary dengue vector, Aedes aegypti (Linn.) from dengue endemic districts of sub-Himalayan West Bengal, India.

Authors:  Minu Bharati; Dhiraj Saha
Journal:  PLoS One       Date:  2018-09-10       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.